Article Sidebar

PDF
Date Published: 08/07/2022
Online Published: 08/07/2022
Abstract Views: 227
Views PDF: 168
DOI: https://doi.org/10.55046/vjrnm.31.544.2018
Issue
No. 31 (2018)
Section
Scientific research
How to Cite
Nguyen, V. T. B., & Le, V. P. (2022). The role of endovascular treatment for massive hemoptysis. Vietnamese Journal of Radiology and Nuclear Medicine, 31, 67-72. https://doi.org/10.55046/vjrnm.31.544.2018

The role of endovascular treatment for massive hemoptysis

Dr Nguyen Van Tien Bao1, Dr Le Van Phuoc1
1 Department of Diagnostic Imaging- Cho Ray Hospital

Main Article Content

Abstract

Objectives: To assess the safety and effectiveness of arterial embolization in patients with massive hemoptysis.
Subjects and Method: All patients were diagnosed massive hemoptysis and treated endovascular intervention in Cho Ray Hospital from January 2016 to March 2017. Some variants were asscessed: etiologies, important angiographics findings, the clinical success, complications and follow-up outcomes within 1 month.
Results: 35 patients were treated by endovascular intervention. Massive hemoptysis was caused by bronchiectasis (37,1%), pulmonary tuberculosis (20%), pulmonary aspergilloma 14.3%). A total of 69 bleeding arteries were found, an average of
four arteries per patient. Important angiographics findings were: vascular hypertrophy and tortuosity (80,0%), neovascularity
and hypervascularity (85,7%), shunting (25,7%), aneurysm formation (8,5%) and active extravasation (5,7%). Immediate
clinical success achieved was 97,1% (34/35 patients) and 11,7% of patients had recurrent over 1 month; aspergilloma and
shunting were asociated with early recurrent (p<0,05). No serve complications were reported and the most common complication was trasient chest pain (28,6%). 
Conclusion: Endovascular treament is an effective and safe procedure in the management of massive hemoptysis.

Article Details

Keywords

massive hemoptysis, embolized arteries, clinical success,, early recurrent.

References

1. Ayx I., Muller-Wille R., Wohlgemuth W. A., et al. (2017), “Treatment of Acute Hemoptysis by Bronchial Artery Embolization with the Liquid Embolic Agent Ethylene Vinyl Alcohol Copolymer”, J Vasc Interv Radiol, 28 (6), pp. 825–831.
2. Brown A. C., Ray C. E. (2012), “Anterior Spinal Cord Infarction following Bronchial Artery Embolization”, Semin Intervent Radiol, 29 (3), pp. 241-244.
3. Chun J. Y., Belli A. M. (2010), “Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis”, Eur Radiol, 20 (3), pp. 558-65.
4. Hahn S., Kim Y. J., Kwon W., et al. (2010), “Comparison of the effectiveness of embolic agents for bronchial artery embolization: gelfoam versus polyvinyl alcohol”, Korean J Radiol, 11 (5), pp. 542-6.
5. Lopez J. K., Lee H. Y. (2006), “Bronchial artery embolization for treatment of life-threatening hemoptysis”, Semin Intervent Radiol, 23 (3), pp. 223-9.
6. Remy J., Arnaud A., Fardou H., et al. (1977), “Treatment of hemoptysis by embolization of bronchial arteries”, Radiology, 122 (1), pp. 33-7.
7. Shao H., Wu J., Wu Q., et al. (2015), “Bronchial artery embolization for hemoptysis: a retrospective observational study of 344 patients”, Chin Med J (Engl), 128 (1), pp. 58-62.
8. Shin B., Koh W. J., Shin S. W., et al. (2016), “Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary Aspergillosis”, PLoS One, 11 (12), e0168373.
9. Sopko D. R., Smith T. P. (2011), “Bronchial Artery Embolization for Hemoptysis”, Semin Intervent Radiol, 28 (1), pp. 48-62.
10. Yoon W., Kim J. K., Kim Y. H., et al. (2002), “Bronchial and nonbronchial systemic artery embolization for lifethreatening
hemoptysis: a comprehensive review”, Radiographics, 22 (6), pp. 1395-409.